Radioligand Efficacy Comparison by Initial PSA-Response Outcome in Metastatic CRPC with Lutetium 177Lu PSMA RLT (RECIPROCAL)
Eligible for screening study DCP 001
Completion of Pre-Registration QOLs is required after consent, prior to registration. Please see study documents.
